Press Release Mar 24 2023
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release announcing the final approval from the USFDA for Lubiprostone Capsules in two dosages. The capsules are indicated for treating specific types of constipation and will be manufactured in Ahmedabad, India.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Mar 21 2023
- Press Release Mar 15 2023
- Press Release Mar 09 2023
- Press Release Mar 07 2023
- Press Release Mar 03 2023
Later from Zydus Lifesciences
- Press Release Mar 25 2023
- Press Release Mar 28 2023
- Press Release Apr 06 2023
- Press Release Apr 10 2023
- Press Release Apr 11 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences